Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.
J Formos Med Assoc. 2024 Nov;123 Suppl 3:S169-S179. doi: 10.1016/j.jfma.2024.08.018. Epub 2024 Aug 23.
BACKGROUND/PURPOSE: The National Medicines Policy (NMP) is crucial as it sets the framework for ensuring access to affordable, high-quality medicines and promoting their rational use, which is essential for public health and the efficiency of the healthcare system. This study aims to evaluate the current state of Taiwan's NMP, identify pressing issues for improvement, and establish actionable suggestions through expert consensus to ensure the sustainable provision and use of medications.
A modified two-round Delphi technique was employed. The first-round survey identified key issues and suggestions for policy improvement, while the second-round survey evaluated the feasibility and effectiveness of these suggestions. The expert panel, consisting of 50 specialists from pharmacy, medicine, public health, and the pharmaceutical industry, evaluated key issues related to the NMP's efficacy using a 4-point Likert scale.
The first-round survey identified 13 key issues in Taiwan's NMP, primarily focusing on the rational use and accessibility of medications. The second-round survey proposed 54 policy improvement suggestions for these issues, of which 20 were considered strong suggestions and 23 were moderate suggestions. The policy recommendations cover medication reimbursement, pharmacy professional services, administration, legislation, and education.
The study highlights the urgent need for reforms in Taiwan's NMP, providing specific policy improvement suggestions to ensure high-quality medications and pharmaceutical services while supporting the sustainable operation of Taiwan's NHI system. The study underscores the significance of proactive measures to fortify healthcare sustainability in the face of evolving healthcare landscapes.
背景/目的：国家药品政策（NMP）至关重要，因为它为确保获得负担得起的高质量药品并促进其合理使用提供了框架，这对公共卫生和医疗保健系统的效率至关重要。本研究旨在评估台湾现行 NMP 的状况，确定需要改进的紧迫问题，并通过专家共识建立可行的建议，以确保药物的可持续供应和使用。
采用改良的两轮德尔菲技术。第一轮调查确定了政策改进的关键问题和建议，第二轮调查评估了这些建议的可行性和有效性。专家小组由来自药学、医学、公共卫生和制药行业的 50 名专家组成，他们使用 4 分制量表评估与 NMP 疗效相关的关键问题。
第一轮调查确定了台湾 NMP 中的 13 个关键问题，主要集中在药物的合理使用和可及性上。第二轮调查针对这些问题提出了 54 项政策改进建议，其中 20 项被认为是强烈建议，23 项是中度建议。政策建议涵盖了药物报销、药房专业服务、管理、立法和教育。
本研究强调了台湾 NMP 急需改革，提出了具体的政策改进建议，以确保高质量的药物和药品服务，同时支持台湾健保制度的可持续运作。该研究强调了积极措施对于加强医疗保健可持续性的重要性，以应对不断变化的医疗保健格局。
